SalA upregulates BDNF, thereby activating the PI3K/Akt signaling pathway. Additionally, SalA inhibits GSK-3, promoting antiapoptotic and neurogenic pathways. The prevention of p25 generation and Cdk5 activation by SalA confers further benefits in the context of stroke. The gene discussed is AKT1; the disease is stroke disorder.